Cytomegalovirus (re)activation plays no role in the ocular vitritis observed after initiation of highly active antiretroviral therapy.
Boyraz-Ikiz
H D
HD
Witmer
J P
JP
Frissen
P H
PH
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000821:virology; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000254:growth & development*; D017726:Cytomegalovirus Retinitis / Q000150:complications / Q000188:drug therapy / Q000821:virology; D005128:Eye Diseases / Q000821:virology; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D008297:Male; D014775:Virus Activation; D014822:Vitreous Body / Q000276:immunology / Q000473:pathology / Q000821:virology*
D019380:Anti-HIV Agents